To view this email as a web page, click here.

 
Aesthetics
 
Dermatology Times
Revive joins Belotero product range in Europe
Merz announced the launch of Belotero Revive, Friday, April 5, in selected countries in Europe and Latin America.
ADVERTISEMENT
 
Examining facial skeletal changes in black and white adults
image description here Both black and white adults experience facial skeletal changes, but the degree of change that researchers observed in black adults over about a 10-year period was minor compared to their previous findings among white patients.

 
ADVERTISEMENT
Filler-phobic patients? Here’s another option.
What options are available for patients who want longer-term revitalization of their skin with minimal downtime? Find out in this podcast that discuss the evolution of microneedling. Listen to the podcast now.
 
Practice Management
 
How to attract loyal patients
image description here Ryan Suydam, chief experience officer at Client Savvy, wants your patients to have an excellent experience. That’s why he’s sharing his top five tips to improve the patient experience, which will not only help you attract new patients – it will keep your current patients coming back to your practice.

 
Comorbidities in psoriasis
 
Psoriatic arthritis and hearing impairment
image description here The first multicentered study to evaluate hearing in psoriatic arthritis found that patients with the condition may have mild hearing loss compated to their age-matched controls. But more research is needed to elucidate what is causing hearing impairment in this patient population.

 
From our Latest Issue
 
Dermatology Times cover
Better safety profile for new retinoid in development
 
Cosmetic procedures more than vanity
 
Future of skin resurfacing lies in drug delivery, postprocedural care
 
JOB OPPORTUNITIES
 
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.